Literature DB >> 19695487

A missed point in deciphering the viral synergy between herpes simplex virus and HIV.

Andrea Lisco, Christophe Vanpouille, Leonid Margolis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19695487      PMCID： PMC3427854          DOI： 10.1016/S1473-3099(09)70209-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  15 in total

1.  AIDS research. Promising prevention interventions perform poorly in trials.

Authors:  Jon Cohen
Journal:  Science       Date:  2007-07-27       Impact factor: 47.728

2.  Herpes simplex virus and HIV-1: deciphering viral synergy.

Authors:  Rex G Cheng; Douglas F Nixon
Journal:  Lancet Infect Dis       Date:  2009-02       Impact factor: 25.071

3.  The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation.

Authors:  Moira A McMahon; Janet D Siliciano; Jun Lai; Jun O Liu; James T Stivers; Robert F Siliciano; Rahul M Kohli
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

4.  Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers.

Authors:  S Weller; M R Blum; M Doucette; T Burnette; D M Cederberg; P de Miranda; M L Smiley
Journal:  Clin Pharmacol Ther       Date:  1993-12       Impact factor: 6.875

5.  Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.

Authors:  Richard A Zuckerman; Aldo Lucchetti; William L H Whittington; Jorge Sanchez; Robert W Coombs; Rosario Zuñiga; Amalia S Magaret; Anna Wald; Lawrence Corey; Connie Celum
Journal:  J Infect Dis       Date:  2007-10-31       Impact factor: 5.226

6.  Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.

Authors:  Rachna Gupta; Anna Wald; Elizabeth Krantz; Stacy Selke; Terri Warren; Mauricio Vargas-Cortes; Gerri Miller; Lawrence Corey
Journal:  J Infect Dis       Date:  2004-09-20       Impact factor: 5.226

7.  Lack of bioequivalence between two aciclovir tablets in healthy subjects.

Authors:  Hossein Amini; Mohammad Javan; Parisa Gazerani; Alireza Ghaffari; Abolhassan Ahmadiani
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

8.  Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.

Authors:  Nicolas Nagot; Abdoulaye Ouédraogo; Vincent Foulongne; Issouf Konaté; Helen A Weiss; Laurence Vergne; Marie-Christine Defer; Didier Djagbaré; Anselme Sanon; Jean-Baptiste Andonaba; Pierre Becquart; Michel Segondy; Roselyne Vallo; Adrien Sawadogo; Philippe Van de Perre; Philippe Mayaud
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

9.  Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.

Authors:  Deborah Watson-Jones; Helen A Weiss; Mary Rusizoka; John Changalucha; Kathy Baisley; Kokugonza Mugeye; Clare Tanton; David Ross; Dean Everett; Tim Clayton; Rebecca Balira; Louise Knight; Ian Hambleton; Jerome Le Goff; Laurent Belec; Richard Hayes
Journal:  N Engl J Med       Date:  2008-03-12       Impact factor: 91.245

10.  HIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell counts.

Authors:  Jason D Barbour; Mariana M Sauer; Elizabeth R Sharp; Keith E Garrison; Brian R Long; Helena Tomiyama; Katia C Bassichetto; Solange M Oliveira; Maria C Abbate; Douglas F Nixon; Esper G Kallas
Journal:  PLoS One       Date:  2007-10-24       Impact factor: 3.240
View more
  3 in total

1.  Clinical reactivations of herpes simplex virus type 2 infection and human immunodeficiency virus disease progression markers.

Authors:  Bulbulgul Aumakhan; Charlotte A Gaydos; Thomas C Quinn; Chris Beyrer; Lorie Benning; Howard Minkoff; Daniel J Merenstein; Mardge Cohen; Ruth Greenblatt; Marek Nowicki; Kathryn Anastos; Stephen J Gange
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

2.  Time to refocus on HSV interventions for HIV prevention?

Authors:  Clare Tanton; Laith J Abu-Raddad; Helen A Weiss
Journal:  J Infect Dis       Date:  2011-10-12       Impact factor: 5.226

3.  Deciphering the epidemic synergy of herpes simplex virus type 2 (HSV-2) on human immunodeficiency virus type 1 (HIV-1) infection among women in sub-Saharan Africa.

Authors:  Musie Ghebremichael; Desale Habtzgi; Elijah Paintsil
Journal:  BMC Res Notes       Date:  2012-08-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.